- We have been advocating OTC birth control for years.
- Adverse selection problems in insurance markets go away if people must insure by household rather than as individuals. At least in Pakistan.
- Is your doctor employed by a private equity firm? (NYT)
- AARP Represents Health Insurers, Not Seniors
- Is compression of morbidity being reversed? Considering 300 diseases in the USA from 1990 vs. 2017, health span (health-adjusted life expectancy) grew by 2 years, but life expectancy grew by 3 years.
- The Health Care Blog goes wacko: “The greatest health equity threat to Medicaid – and Medicare – beneficiaries is the climate crisis.”
Category: Drug Prices & Regulations
Thursday Links
- Generic drug prices are falling. That’s good news for consumers unless the drug is not available.
- Study: China’s New Cooperative Medical Scheme has saved lives, increased life expectancy.
- Poland experienced five decades of a planned economy, followed by three decades of market orientation. The market is better.
- Pre Obamacare, Did Health Insurance Companies Refuse to Insure a Lot of People?
- Why do so many private schools look just like public schools?
Wednesday Links
- California considers affirmative action for prison sentences.
- Arnold Kling against marijuana.
- “We propose a new priority review voucher program to incentivize competition in limited-competition, small molecule generics markets.”
- Study: “We estimate that the recently proposed US price controls on drugs in the US would raise health care spending by $50.8 billion over a 20-year period.”
Monday Links
- British patients are not grateful for the free care they receive from the NHS.
- Pfizer: antibiotic shortage could worsen syphilis epidemic. (NYT)
- Should you worry about “forever chemicals” in your drinking water?
- Turley to Zuckerberg: “Release the Facebook Files.”
- Evidence lacking that dietary supplements sharpen the mind.
- Negative results from Portugal’s experiment with decriminalization of drug use.
- Another article on drug shortages that fails to ask the obvious question: Why isn’t there a shortage of aspirin?